Literature DB >> 24157130

Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.

Domenico Plantone1, Alessandro Marti, Giovanni Frisullo, Raffaele Iorio, Valentina Damato, Viviana Nociti, Agata Katia Patanella, Assunta Bianco, Massimiliano Mirabella, Anna Paola Batocchi.   

Abstract

In this study we evaluated the percentages of CD3(-)CD56(bright), CD3(-)CD56(dim), CD3(-)CD56(bright)perforin(+) and CD3(-)CD56(dim)perforin(+) Natural Killer (NK) cells in peripheral blood from untreated secondary progressive (SP) and primary progressive (PP) multiple sclerosis (MS) patients and age and sex matched healthy subjects. Both PPMS patients and SPMS patients showed increased percentages of circulating CD3(-)CD56(dim)perforin(+) NK cells than healthy subjects. The increased percentage of CD3(-)CD56(dim) NK cells expressing perforin in patients affected by the progressive forms of MS suggests a possible role of this NK cell subpopulation in the pathogenesis of the disease.
© 2013.

Entities:  

Keywords:  Cytotoxicity; Natural Killer cells; Progressive multiple sclerosis

Mesh:

Substances:

Year:  2013        PMID: 24157130     DOI: 10.1016/j.jneuroim.2013.10.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

Review 1.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

2.  Dimethyl fumarate may still have a role in progressive multiple sclerosis.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  Ther Adv Neurol Disord       Date:  2016-04-06       Impact factor: 6.570

Review 3.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 4.  The immunology of multiple sclerosis.

Authors:  Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2022-05-04       Impact factor: 53.106

5.  Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.

Authors:  A H Cross; L Piccio; E E Longbrake; M J Ramsbottom; C Cantoni; L Ghezzi
Journal:  Mult Scler       Date:  2015-10-12       Impact factor: 6.312

6.  Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.

Authors:  Vanessa F Moreira Ferreira; Yanqing Liu; Brian C Healy; James M Stankiewicz
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-04-29

Review 7.  The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Samuel S Duffy; Justin G Lees; Gila Moalem-Taylor
Journal:  Mult Scler Int       Date:  2014-10-12

8.  Activation of Blood CD3+CD56+CD8+ T Cells during Pregnancy and Multiple Sclerosis.

Authors:  Clara de Andrés; Lidia Fernández-Paredes; Marta Tejera-Alhambra; Bárbara Alonso; Rocío Ramos-Medina; Silvia Sánchez-Ramón
Journal:  Front Immunol       Date:  2017-02-23       Impact factor: 7.561

Review 9.  γδ T Cells and NK Cells - Distinct Pathogenic Roles as Innate-Like Immune Cells in CNS Autoimmunity.

Authors:  Sarah C Edwards; Aoife M McGinley; Niamh C McGuinness; Kingston H G Mills
Journal:  Front Immunol       Date:  2015-09-08       Impact factor: 7.561

10.  High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.

Authors:  Felicitas Escher; Uwe Kühl; Dirk Lassner; Andrea Stroux; Ulrich Gross; Dirk Westermann; Burkert Pieske; Wolfgang Poller; Heinz-Peter Schultheiss
Journal:  J Am Heart Assoc       Date:  2017-08-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.